Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RECORLEV safely and effectively. See full prescribing information for RECORLEV. RECORLEV (levoketoconazole) tablets, oral Initial U.S. Approval: 1981 (ketoconazole)
Medication labelWhy this: Advisory · dailymed-prescription
RECORLEV is indicated for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an option or has not been curative. Limitations of Use RECORLEV is not approved for the treatment of fungal infections. The safety and effectiveness of RECORLEV for the treatment of fungal infections have not been established.
- generic_name
- levoketoconazole
- product_names
- Levoketoconazole
- ndc
- 72065-003, 72065-003-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en